Instrument manufacturer Bruker to exit underperforming instrument lines
Bruker announced a few days ago (see the announcement dated July 23) the decision to reduce its Chemical & Applied Markets (CAM) Division product portfolio. As a result of this decision, Bruker will stop selling its stand-alone GC systems and its single-quadrupole (SQ) GC-SQ mass spectrometry systems.
In their statement the company said that its CAM division, which houses these products, has generated significant losses for the last four years, with little prospect of near-term profitability.
Bruker will honour outstanding orders for the affected GC and GC-MS instruments, but is not taking any new orders. Ordered instruments will be delivered and installed and the company will continue to provide service and support for these products and there will be no change in customer service.
The company is looking to sell off its ICP-MS business, and for someone to take over the service contracts for the GC instruments. The company expect to transfer the ICP-MS business to a global, high-quality analytical instruments company with a broader trace elemental analysis portfolio in the next few months.
At the same time, Bruker is expanding its microscopy offering in the life sciences, by acquiring US start-up Vutara for its high speed, 3D, super resolution fluorescence microscopy technology. The companies did not disclose financial details of the transaction. Related information
Bruker: Press release July 23, 2014 Related EVISA Resources Company Database: Bruker Corporation Instrument Database: Bruker's line of ICP-MS instruments Instrument Database: Bruker's line of GC instruments Related EVISA News January 28, 2014: Bruker introduces new Bruker Advance HPLC for ICP-MS February 11, 2013: Bruker launched its new aurora Elite ICP-MS instrument with spectacular sensitivity specs March 10, 2010: Bruker and Agilent Technologies Announce Agreement for Bruker to Acquire Certain Varian Inc. Product Lines
last time modified: August 4, 2014